对大脑转移的放射治疗:2025年更新
Delphine Antoni1, Emmanuel Mesny2, Osman El Kabbaj3
1Radiation Oncology Department, Institut de cancérologie Strasbourg Europe, Strasbourg, France.
概括
法国辐射瘤学会最新的指导方针提供了通过放射治疗管理大脑转移的建议. 这些指导方针解决了复杂的挑战,旨在实现个性化的治疗策略,并尽量减少副作用,以改善患者的治疗结果.
科学领域:
- 辐射瘤学 辐射瘤学
- 神经瘤学神经瘤学
- 医疗成像医学成像
背景情况:
- 大脑转移的管理越来越复杂,因为患者的存活时间越长,系统疗法的进展也越来越多.
- 影像和放射治疗的技术进步需要更新的治疗方案.
- 个性化预后分类和代放射治疗的可能性需要仔细考虑.
研究的目的:
- 介绍法国辐射瘤学会 (SFRO) 关于脑转移放射治疗的最新建议.
- 在脑转移管理中概述放射治疗的指示和技术方法.
- 强调多学科和个性化治疗策略的重要性.
主要方法:
- 通过SFRO对当前证据和临床专业知识的审查和综合.
- 根据预后分类和治疗进展,制定更新的指导方针.
- 专注于将放射治疗与全身疗法相结合,并管理副作用.
主要成果:
- 确立了脑转移患者放射治疗的最新指示.
- 定义了放射治疗的技术模式,包括剂量分成和输送技术.
- 强调需要个性化治疗规划和随访.
结论:
- 放射治疗仍然是治疗大脑转移的基石.
- 个性化,多学科的策略对于优化疗效和最小化毒性至关重要.
- 建议强调根据疾病演变和患者状况调整治疗.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


